Search
for
Sort by
Research 811–840 of 1000+
- The Role of Minoxidil in Treatment of Alopecia Areata: A Systematic Review and Meta-Analysis
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
- Ivarmacitinib stimulates hair regrowth in severe alopecia areata
- Inhibition of Wnt/β‐catenin pathway promotes regenerative repair of cutaneous and cartilage injury
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Alopecia areata treatment with baricitinib: different relapse phenotypes
- Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib
- Unmasking Melasma: Confronting the Treatment Challenges
- Jiawei Erzhiwan Ameliorates Androgenetic Alopecia by Regulating the SIRT1/JNK/p38 MAPK Pathway
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- Application of Baricitinib in Dermatology
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- JAK1 Signaling Is Involved in the Induction of Mechanical Alloknesis in Atopic Dermatitis
- A Single Subcutaneous Dose of BMD-1141 Stimulates Hair Regrowth Comparable to Daily, High-Dose Ruxolitinib in a Mouse Model of Alopecia Areata.
- Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- “PRIDE” Complex
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Abrocitinib in the Treatment of Severe Alopecia Areata in a Pediatric Patient: A Case Report
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Stem cell-based therapies for alopecia areata: a narrative review